• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状原发性血小板增多症伴肝外门静脉血栓形成:病例报告。

Asymptomatic Essential Thrombocytosis Presenting with Extrahepatic Portal Vein Thrombosis: A Case Report.

机构信息

Department of Internal Medicine, Komatsu Hospital, Neyagawa, Osaka, Japan.

Department of Internal Medicine, Higashi-Osaka Hospital, Osaka, Japan.

出版信息

Am J Case Rep. 2023 Sep 28;24:e938547. doi: 10.12659/AJCR.938547.

DOI:10.12659/AJCR.938547
PMID:37766423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10546070/
Abstract

BACKGROUND Essential thrombocytosis (ET) is a myeloproliferative neoplasm variant that leads to excessive platelet production in the bone marrow. Janus kinase 2 (JAK2) mutation is observed in 60% of ET cases. The risk of thrombosis increases with the presence of this mutation. ET can cause systemic thrombosis, including extra-portal vein thrombosis (EHPVT). In patients with ET-induced EHPVT, varied symptoms generally occur. However, our case was asymptomatic. This condition is relatively rare. CASE REPORT A 49-year-old woman presented to our hospital for a detailed clinical examination 1 month after a health examination, and blood tests revealed microcytic anemia and thrombocytosis. The patient had no current concerns and had no relevant medical or alcohol consumption history. Esophagogastroduodenoscopy demonstrated esophageal varices, with portal hypertension suspected as the underlying cause. Contrast-enhanced computed tomography scans revealed a thrombus in the portal vein, but liver cirrhosis and a tumor were ruled out. JAK2 mutation was positive, which led to myeloproliferative neoplasms being considered as the differential diagnosis. Bone marrow biopsy demonstrated many mature megakaryocytes with large and irregular nuclei and platelet aggregation in the field of view, leading to the diagnosis of ET. CONCLUSIONS This case study describes a patient with EHPVT caused by JAK2-positive ET. This case report emphasizes that physicians should consider myeloproliferative neoplasms as part of their differential diagnosis when presented with EHPVT.

摘要

背景

特发性血小板增多症(ET)是一种骨髓增生性肿瘤,可导致骨髓中血小板过度生成。60%的 ET 病例存在 JAK2 突变。存在这种突变会增加血栓形成的风险。ET 可导致全身性血栓形成,包括门静脉以外血栓形成(EHPVT)。在 ET 引起的 EHPVT 患者中,通常会出现各种症状。然而,我们的病例患者无症状。这种情况相对罕见。

病例报告

一名 49 岁女性在健康检查后 1 个月因详细临床检查就诊于我院,血液检查显示小细胞性贫血和血小板增多。患者目前无任何不适,也无相关医疗或饮酒史。食管胃十二指肠镜检查显示食管静脉曲张,疑为门静脉高压所致。增强 CT 扫描显示门静脉内有血栓,但排除了肝硬化和肿瘤。JAK2 突变阳性,考虑为骨髓增生性肿瘤的鉴别诊断。骨髓活检显示视野中有许多成熟的巨核细胞,细胞核大且不规则,血小板聚集,诊断为 ET。

结论

本病例研究描述了一例 JAK2 阳性 ET 引起的 EHPVT 患者。本病例报告强调,当遇到 EHPVT 时,医生应将骨髓增生性肿瘤作为鉴别诊断的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/c827d3be2b64/amjcaserep-24-e938547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/367a3016bf5f/amjcaserep-24-e938547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/750522f732b5/amjcaserep-24-e938547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/c827d3be2b64/amjcaserep-24-e938547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/367a3016bf5f/amjcaserep-24-e938547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/750522f732b5/amjcaserep-24-e938547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfa/10546070/c827d3be2b64/amjcaserep-24-e938547-g003.jpg

相似文献

1
Asymptomatic Essential Thrombocytosis Presenting with Extrahepatic Portal Vein Thrombosis: A Case Report.无症状原发性血小板增多症伴肝外门静脉血栓形成:病例报告。
Am J Case Rep. 2023 Sep 28;24:e938547. doi: 10.12659/AJCR.938547.
2
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.JAK2 V617F 阳性潜伏性原发性血小板增多症与内脏静脉血栓形成:骨髓活检在骨髓增殖性疾病诊断中的作用
Acta Haematol. 2009;121(4):218-20. doi: 10.1159/000221962. Epub 2009 May 29.
3
Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis.由特发性血小板增多症伴局限性皮肤系统性硬皮病引起的门静脉血栓形成。
Clin J Gastroenterol. 2021 Feb;14(1):293-296. doi: 10.1007/s12328-020-01274-6. Epub 2020 Nov 2.
4
[Deep vein thrombosis revealing myeloproliferative syndrome in two adolescents].
Arch Pediatr. 2014 May;21(5):497-500. doi: 10.1016/j.arcped.2014.02.019. Epub 2014 Apr 6.
5
JAK2 mutation-negative essential thrombocythemia in a child presenting with cerebral venous thrombosis.一名出现脑静脉血栓形成的儿童的JAK2突变阴性原发性血小板增多症
Hematol Oncol Stem Cell Ther. 2012;5(1):66-8. doi: 10.5144/1658-3876.2012.66.
6
JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.JAK2(V617F)阳性早期骨髓增殖性疾病(原发性血小板增多症)作为两名中年女性门静脉血栓形成的原因:基于文献的治疗意义
Ann Hematol. 2007 Nov;86(11):793-800. doi: 10.1007/s00277-007-0351-1. Epub 2007 Aug 9.
7
[Portal vein thrombosis as the main symptom of unclassified JAK2-positive myeloproliferative neoplasm--case report].[以门静脉血栓形成作为未分类JAK2阳性骨髓增殖性肿瘤的主要症状——病例报告]
Pol Merkur Lekarski. 2012 Jul;33(193):29-31.
8
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.真性红细胞增多症和原发性血小板增多症:2017 年诊断、危险分层和治疗更新。
Am J Hematol. 2017 Jan;92(1):94-108. doi: 10.1002/ajh.24607.
9
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.真性红细胞增多症和原发性血小板增多症:2015 年诊断、风险分层和治疗更新。
Am J Hematol. 2015 Feb;90(2):162-73. doi: 10.1002/ajh.23895.
10
Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm.门静脉血栓形成作为JAK2阳性骨髓增殖性肿瘤的首发表现
Am J Med Sci. 2023 May;365(5):457-461. doi: 10.1016/j.amjms.2023.01.002. Epub 2023 Jan 9.

本文引用的文献

1
Mutations and thrombosis in essential thrombocythemia.原发性血小板增多症中的突变与血栓形成
Blood Cancer J. 2021 Apr 27;11(4):77. doi: 10.1038/s41408-021-00470-y.
2
Gastroesophageal varices in a patient presenting with essential thrombocythemia: A case report.一名原发性血小板增多症患者出现胃食管静脉曲张:病例报告。
World J Clin Cases. 2021 Mar 16;9(8):1871-1876. doi: 10.12998/wjcc.v9.i8.1871.
3
Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis.由特发性血小板增多症伴局限性皮肤系统性硬皮病引起的门静脉血栓形成。
Clin J Gastroenterol. 2021 Feb;14(1):293-296. doi: 10.1007/s12328-020-01274-6. Epub 2020 Nov 2.
4
Essential Thrombocythemia.原发性血小板增多症
N Engl J Med. 2019 Nov 28;381(22):2135-2144. doi: 10.1056/NEJMcp1816082.
5
Essential thrombocythemia treatment algorithm 2018.2018 年原发性血小板增多症治疗算法
Blood Cancer J. 2018 Jan 10;8(1):2. doi: 10.1038/s41408-017-0041-8.
6
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.用于真性红细胞增多症和原发性血小板增多症的抗血小板药物。
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD006503. doi: 10.1002/14651858.CD006503.pub3.
7
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.布加综合征和门静脉血栓形成中的骨髓增殖性肿瘤:一项荟萃分析。
Blood. 2012 Dec 13;120(25):4921-8. doi: 10.1182/blood-2011-09-376517. Epub 2012 Oct 4.
8
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.JAK2V617F 突变对伴有门脉系统血栓形成的非费城染色体阴性慢性骨髓增殖性肿瘤患者的临床意义。
J Thromb Thrombolysis. 2012 Oct;34(3):388-96. doi: 10.1007/s11239-012-0738-2.
9
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.386例连续性原发性血小板增多症患者的长期随访:血细胞减少治疗的安全性
Am J Hematol. 2009 Apr;84(4):215-20. doi: 10.1002/ajh.21360.
10
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.原发性血小板增多症和真性红细胞增多症患者的凝血酶生成及活化蛋白C抵抗
Blood. 2008 Nov 15;112(10):4061-8. doi: 10.1182/blood-2008-06-164087. Epub 2008 Sep 3.